Javier Rueda‐Gotor

1.8k total citations
54 papers, 837 citations indexed

About

Javier Rueda‐Gotor is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Javier Rueda‐Gotor has authored 54 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Rheumatology, 14 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Javier Rueda‐Gotor's work include Spondyloarthritis Studies and Treatments (20 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and Psoriasis: Treatment and Pathogenesis (10 papers). Javier Rueda‐Gotor is often cited by papers focused on Spondyloarthritis Studies and Treatments (20 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and Psoriasis: Treatment and Pathogenesis (10 papers). Javier Rueda‐Gotor collaborates with scholars based in Spain, South Africa and United States. Javier Rueda‐Gotor's co-authors include Ricardo Blanco, Miguel Á. González‐Gay, Javier Llorca, Alfonso Corrales, Marcos A. González‐López, Carlos González‐Juanatey, F. Ortíz-Sanjuán, Cristina Mata, J. Loricera and V. Calvo-Río and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Javier Rueda‐Gotor

51 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Rueda‐Gotor Spain 17 533 259 187 162 110 54 837
Lillian Barra Canada 18 658 1.2× 373 1.4× 322 1.7× 140 0.9× 98 0.9× 53 1.2k
Maria Letizia Urban Italy 21 611 1.1× 348 1.3× 224 1.2× 152 0.9× 110 1.0× 53 1.1k
H. Devilliers France 17 637 1.2× 405 1.6× 209 1.1× 113 0.7× 261 2.4× 69 990
Kiyoshi Takasugi Japan 18 461 0.9× 114 0.4× 209 1.1× 401 2.5× 129 1.2× 51 1.0k
Marcos A. González‐López Spain 18 351 0.7× 307 1.2× 222 1.2× 132 0.8× 268 2.4× 69 1.1k
Loukas Settas Greece 16 819 1.5× 144 0.6× 349 1.9× 107 0.7× 72 0.7× 28 1.2k
Jess D. Edison United States 17 1.0k 1.9× 110 0.4× 332 1.8× 194 1.2× 90 0.8× 39 1.5k
I. Koetter Germany 16 267 0.5× 146 0.6× 283 1.5× 276 1.7× 87 0.8× 28 844
Antonio Iglesias Gamarra Colombia 17 398 0.7× 150 0.6× 144 0.8× 89 0.5× 56 0.5× 94 705
Sophie Dimonaco United Kingdom 11 921 1.7× 861 3.3× 243 1.3× 108 0.7× 110 1.0× 18 1.5k

Countries citing papers authored by Javier Rueda‐Gotor

Since Specialization
Citations

This map shows the geographic impact of Javier Rueda‐Gotor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Rueda‐Gotor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Rueda‐Gotor more than expected).

Fields of papers citing papers by Javier Rueda‐Gotor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Rueda‐Gotor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Rueda‐Gotor. The network helps show where Javier Rueda‐Gotor may publish in the future.

Co-authorship network of co-authors of Javier Rueda‐Gotor

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Rueda‐Gotor. A scholar is included among the top collaborators of Javier Rueda‐Gotor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Rueda‐Gotor. Javier Rueda‐Gotor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rueda‐Gotor, Javier, et al.. (2024). AB0966 UVEITIS IN AXIAL SPONDYLOARTHRITIS: STUDY OF 309 PATIENTS IN A SINGLE UNIVERSITY CENTER. Annals of the Rheumatic Diseases. 83. 1796–1797.
2.
Rueda‐Gotor, Javier, Juan Carlos Quevedo-Abeledo, Alfonso Corrales, et al.. (2020). Reclassification into very-high cardiovascular risk after carotid ultrasound in patients with axial spondyloarthritis.. Clinical and Experimental Rheumatology. 38(4). 724–731. 10 indexed citations
3.
Corrales, Alfonso, N. Vegas-Revenga, Javier Rueda‐Gotor, et al.. (2020). Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study. Seminars in Arthritis and Rheumatism. 50(6). 1333–1338. 31 indexed citations
4.
Corrales, Alfonso, N. Vegas-Revenga, Belén Atienza‐Mateo, et al.. (2020). Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis. Lara D. Veeken. 60(6). 2801–2807. 19 indexed citations
5.
Rueda‐Gotor, Javier, Fernanda Genre, Alfonso Corrales, et al.. (2018). Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound. Arthritis Research & Therapy. 20(1). 195–195. 5 indexed citations
6.
Rueda‐Gotor, Javier, Fernanda Genre, Alfonso Corrales, et al.. (2018). Relative Risk Chart Score for the Assessment of the Cardiovascular Risk in Young Patients with Ankylosing Spondylitis. International Journal of Rheumatology. 2018. 1–6. 6 indexed citations
8.
Genre, Fernanda, Javier Rueda‐Gotor, Sara Remuzgo‐Martínez, et al.. (2018). Association of circulating calprotectin with lipid profile in axial spondyloarthritis. Scientific Reports. 8(1). 13728–13728. 12 indexed citations
9.
Blanco, Ricardo, E. Beltrán, J. Loricera, et al.. (2015). Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review.. PubMed. 32(6). 864–8. 17 indexed citations
10.
Rueda‐Gotor, Javier, Alfonso Corrales, Ricardo Blanco, et al.. (2015). Atherosclerotic disease in axial spondyloarthritis: increased frequency of carotid plaques.. PubMed. 33(3). 315–20. 21 indexed citations
12.
Calvo-Río, V., J. Loricera, Cristina Mata, et al.. (2014). Henoch-Schönlein Purpura in Northern Spain. Medicine. 93(2). 106–113. 93 indexed citations
13.
Genre, Fernanda, Raquel López‐Mejías, José A. Miranda‐Filloy, et al.. (2014). Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy.. PubMed. 32(2). 218–24. 10 indexed citations
14.
Ortíz-Sanjuán, F., Ricardo Blanco, José L. Hernández, et al.. (2014). Drug-associated Cutaneous Vasculitis: Study of 239 Patients from a Single Referral Center. The Journal of Rheumatology. 41(11). 2201–2207. 28 indexed citations
15.
Fonollosa, Alex, Lorea Martínez‐Indart, Joseba Artaraz, et al.. (2014). Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain. Ocular Immunology and Inflammation. 24(2). 1–6. 28 indexed citations
16.
García-Bermúdez, Mercedes, Raquel López‐Mejías, Fernanda Genre, et al.. (2013). SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients. PLoS ONE. 8(10). e77695–e77695. 12 indexed citations
17.
Loricera, J., V. Calvo-Río, F. Ortíz-Sanjuán, et al.. (2013). The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population. Medicine. 92(6). 331–343. 40 indexed citations
18.
Rueda‐Gotor, Javier, Miguel Á. González‐Gay, & Ricardo Blanco. (2012). Tocilizumab for the treatment of rheumatoid arthritis. Clinical Practice. 9(3). 255–268. 10 indexed citations
19.
Rueda‐Gotor, Javier, et al.. (2012). Successful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritis. Joint Bone Spine. 79(5). 510–513. 17 indexed citations
20.
Rueda‐Gotor, Javier & Ricardo Blanco. (2011). Tocilizumab en artritis reumatoide. Reumatología Clínica. 6. 29–32. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026